文献速递神经肌肉病

远端对称性轴索性多发性神经病临床医生评分量表的系统综述

Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review.
PubMed 文献 · Neurology · 2019-07-18

该系统综述汇总了18个已发表的远端对称性轴索性多发性神经病(DSP)临床医生评分量表,分析其内容构成。各量表在运动、反射、大纤维感觉、小纤维感觉和自主神经领域的评分占比差异很大,最常见条目为振动觉、反射和针刺觉。综述可帮助根据DSP表型或治疗靶点选择合适量表。

要点

  • DSP影响至少10%美国人口,现有治疗有限,可靠结局指标对研发新疗法至关重要。
  • 18个量表内容差异大,振动觉(100%)、反射(89%)、针刺觉(78%)最常见。
  • 选择量表应基于目标神经病变量表最受累或实验治疗最可能影响的领域。

核心结论

  • 现有DSP临床医生评分量表在运动、反射、大纤维感觉、小纤维感觉和自主神经领域的评分占比差异很大。
  • 可根据特定DSP人群最受累的领域或实验治疗最可能影响的领域选择合适量表。

研究设计与样本

  • 系统综述,通过PubMed和作者个人档案识别并汇总了18个已发表的DSP临床医生评分量表。

主要发现

  • 各量表在运动、反射、大纤维感觉、小纤维感觉和自主神经领域的评分相对百分比差异很大。
  • 最常见神经检查条目为振动觉(n=18,100%)、反射(n=16,89%)、针刺觉(n=14,78%)。
  • 其他常见条目包括肌力(n=11,61%)、触压觉(n=9,50%)、关节位置觉(n=8,44%)。

临床怎么用

  • 临床医生可根据DSP患者最受累的领域或实验治疗预期影响的领域,从现有量表中选用最合适的临床医生评分量表。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Distal symmetrical axonal polyneuropathy (DSP) is due to injury to peripheral sensory, motor, and autonomic nerve fibers, resulting in distal predominant sensory loss, pain, and gait instability. DSP occurs as a complication of multiple medical conditions including diabetes or HIV, or following exposure to various toxins such as chemotherapy. It affects at least 10% of the United States population. Few treatments for DSP are approved by regulatory agencies. Reliable and responsive outcome measures are integral to developing new DSP treatments. Multiple clinician-rated measures that incorporate neuropathy signs exist, however, it is not clear which of these measures performs best for various DSP phenotypes. This systematic review summarizes the content of 18 published measures of DSP identified using PubMed and from personal archives of the authors. The relative percentage of scoring dedicated to motor, reflex, large and small fiber sensory, and autonomic domains varied considerably among measures. The most common neurologic examination items included in the scales were (1) vibration perception (n = 18, 100%), (2) reflexes (n = 16, 89%), (3) pinprick perception (n = 14, 78%), (4) muscle strength (n = 11, 61%), (5) touch-pressure perception (n = 9, 50%), and (6) joint position perception (n = 8, 44%). This review can be used to inform decisions regarding which of the available clinician-rated sign outcome measures would be most appropriate for use in a particular DSP population, based on the domains most affected by that neuropathy or on the domains most likely to be affected by a particular experimental therapy.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gewandter JS, Gibbons CH, Campagnolo M, et al. Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review. Neurology. 2019. PMID: 31320471. doi:10.1212/WNL.0000000000007974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。